Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Pacira BioSciences, Inc., a leading innovator in the biopharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has made significant strides in advancing non-opioid pain management solutions, primarily through its flagship product, EXPAREL. This unique formulation of bupivacaine offers extended pain relief while minimising the reliance on opioids, addressing a critical need in postoperative care.
With a strong presence across North America and expanding operations in international markets, Pacira BioSciences has established itself as a key player in the field of analgesia. The company’s commitment to improving patient outcomes and enhancing recovery experiences has garnered recognition, positioning it as a trusted name in pain management. Through continuous innovation and a focus on patient-centric solutions, Pacira BioSciences remains at the forefront of transforming the landscape of pain management therapies.
-19 vs industry average
Pacira BioSciences’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Pacira BioSciences yet.
Pacira BioSciences, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that Pacira BioSciences may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives.
As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Pacira BioSciences to consider setting measurable climate targets and reporting their emissions to align with industry standards and stakeholder expectations. Without specific emissions data or reduction commitments, the company may face challenges in demonstrating its environmental responsibility and commitment to combating climate change.
No climate goals have been disclosed for Pacira BioSciences yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more